vTv Therapeutics Inc. 8-K

What Happened
vTv Therapeutics, Inc. (VTVT) filed a Current Report on Form 8-K on March 10, 2026 (Item 7.01) to disclose that it posted an updated investor slide presentation on its website. The presentation is attached to the filing as Exhibit 99.1 (dated March 2026) and the company says representatives will use it in meetings with investors, analysts and other parties. The filing was signed by Paul J. Sekhri, President and Chief Executive Officer.

Key Details

• Filing date: March 10, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Exhibit: Updated investor presentation attached as Exhibit 99.1 (vTv Therapeutics' Investor Presentation dated March 2026).
• Usage: Company representatives will use the presentation in investor/analyst meetings; the presentation may be amended or updated and further disclosed later.
• Signed by: Paul J. Sekhri, President & CEO.

Why It Matters
This 8-K supplies vTv’s current investor presentation and is a Regulation FD disclosure, meaning the company is broadly disseminating this material to avoid selective disclosure. Retail investors should review the slides on vTv’s website to see the company’s latest messaging about strategy, programs, or updates; the filing itself does not include earnings, executive changes, or other material financial results.